These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 1196832)
1. Is muscular dystrophy a primary myopathy? Pope RS Perspect Biol Med; 1975; 18(2):287-91. PubMed ID: 1196832 [No Abstract] [Full Text] [Related]
2. [Characteristics of lipid metabolism of the skeletal muscles in progressive muscular dystrophy]. Badalian LO; Grinio LP; Temin PA; Islamova IB; Il'in IL Pediatriia; 1983 Jan; (1):66-8. PubMed ID: 6340057 [No Abstract] [Full Text] [Related]
3. An injury model myopathy mimicking dystrophy: implications regarding the function of dystrophin. Stauber WT; Fritz VK; Clarkson PM; Riggs JE Med Hypotheses; 1991 Aug; 35(4):358-62. PubMed ID: 1943889 [TBL] [Abstract][Full Text] [Related]
4. Possible involvement of taurine in the genesis of muscular dystrophy. Baskin SI; Dagirmanjian R Nature; 1973 Oct; 245(5426):464-5. PubMed ID: 4356151 [No Abstract] [Full Text] [Related]
6. [Sympathetic mediator theory of the pathogenesis of progressive muscular dystrophies (a review)]. Badalian LO; Temin PA; Dzhabarov BD; Il'in IL; Kovaleva MIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1722-6. PubMed ID: 6119861 [No Abstract] [Full Text] [Related]
7. [Membrane theory of the pathogenesis of progressive muscular dystrophy]. Badalian LO; Temin PA; Il'in IL; Kovaleva MIu; Dzutova ED Klin Med (Mosk); 1982 Oct; 60(10):13-6. PubMed ID: 6757558 [No Abstract] [Full Text] [Related]
8. [Research on the molecular mechanisms of the pathogenesis of myodystrophies and the systematic approach to the study of human proteins (a review)]. Shishkin SS; Kovalev LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(3):119-23. PubMed ID: 3289286 [No Abstract] [Full Text] [Related]
9. [Role of neurotrophic control in the pathogenesis of muscular dystrophy (a review)]. Bogdanov EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):452-9. PubMed ID: 3518319 [No Abstract] [Full Text] [Related]
10. Treatment of muscular dystrophy. Bradley WG; Polgar JG; Williams MH; Boddie HG Br Med J; 1972 Sep; 3(5828):699-700. PubMed ID: 4650857 [No Abstract] [Full Text] [Related]
11. Glucagon treatment for muscular dystrophy in the mouse. Pope RS Am J Physiol; 1973 Sep; 225(3):518-20. PubMed ID: 4726484 [No Abstract] [Full Text] [Related]
12. [Duchenne's myodystrophy--a hereditary defect of the cell membranes]. Khrennikov VIu Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(3):22-4. PubMed ID: 1646530 [TBL] [Abstract][Full Text] [Related]
14. Studies of healthy relatives of patients with Duchenne muscular dystrophy. Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Hetnarska L; Emeryk B; Wasowicz B; Askanas W; Slucka C J Neurol Sci; 1968; 7(3):465-80. PubMed ID: 4974630 [No Abstract] [Full Text] [Related]
15. Duchenne muscular dystrophy: assessment of experimental data from animals in relation to the human disease. Elbrink J; Malhotra SK; Hunter EG Med Hypotheses; 1987 Jun; 23(2):131-6. PubMed ID: 3614006 [TBL] [Abstract][Full Text] [Related]
16. Treatment of muscular dystrophies. Kingston WJ; Moxley RT Gen Pharmacol; 1989; 20(3):263-8. PubMed ID: 2663627 [TBL] [Abstract][Full Text] [Related]
17. Glucagon treatment of muscular dystrophic mice: a lack of effect. Yen TT; Allan JA Experientia; 1974 Aug; 30(8):908. PubMed ID: 4413580 [No Abstract] [Full Text] [Related]
18. Nerve, muscle and muscular dystrophy. Bradley WG Dev Med Child Neurol; 1971 Aug; 13(4):528-31. PubMed ID: 5558753 [No Abstract] [Full Text] [Related]
19. Studies on the interrelationship of selenium, vitamin E and sulfur amino acids in a nutritional myopathy of the chick. Scott ML Ann N Y Acad Sci; 1966 Sep; 138(1):82-9. PubMed ID: 5230218 [No Abstract] [Full Text] [Related]
20. Mechanisms of resistance to pathogenesis in muscular dystrophies. Infante JP; Huszagh VA Mol Cell Biochem; 1999 May; 195(1-2):155-67. PubMed ID: 10395079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]